Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab
- Status
- COMPLETED
- Phase
- N/A
Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
- Status
- COMPLETED
- Phase
- PHASE4
TEST: Registry for Endoscopic Head and Neck Surgery
- Status
- TERMINATED
- Phase
- N/A
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of MGA271 in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
- Status
- COMPLETED
- Phase
- N/A
A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery
- Status
- COMPLETED
- Phase
- NA
Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab
- Status
- WITHDRAWN
- Phase
- PHASE3
Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Resistance Training and Physical Functioning in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- NA
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2